Literature DB >> 18938117

Extracellular matrix as a biological scaffold material: Structure and function.

Stephen F Badylak1, Donald O Freytes, Thomas W Gilbert.   

Abstract

Biological scaffold materials derived from the extracellular matrix (ECM) of intact mammalian tissues have been successfully used in a variety of tissue engineering/regenerative medicine applications both in preclinical studies and in clinical applications. Although it is recognized that the materials have constructive remodeling properties, the mechanisms by which functional tissue restoration is achieved are not well understood. There is evidence to support essential roles for both the structural and functional characteristics of the biological scaffold materials. This paper provides an overview of the composition and structure of selected ECM scaffold materials, the effects of manufacturing methods upon the structural properties and resulting mechanical behavior of the scaffold materials, and the in vivo degradation and remodeling of ECM scaffolds with an emphasis on tissue function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938117     DOI: 10.1016/j.actbio.2008.09.013

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  396 in total

1.  Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model.

Authors:  Jessica A DeQuach; Joy E Lin; Cynthia Cam; Diane Hu; Michael A Salvatore; Farah Sheikh; Karen L Christman
Journal:  Eur Cell Mater       Date:  2012-06-05       Impact factor: 3.942

2.  Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization.

Authors:  John M Wallis; Zachary D Borg; Amanda B Daly; Bin Deng; Bryan A Ballif; Gilman B Allen; Diane M Jaworski; Daniel J Weiss
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

3.  Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2.

Authors:  Yunqing Kang; Sungwoo Kim; Ali Khademhosseini; Yunzhi Yang
Journal:  Biomaterials       Date:  2011-05-31       Impact factor: 12.479

Review 4.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

5.  Enzymatic cross-linking of human recombinant elastin (HELP) as biomimetic approach in vascular tissue engineering.

Authors:  Sabrina Bozzini; Liliana Giuliano; Lina Altomare; Paola Petrini; Antonella Bandiera; Maria Teresa Conconi; Silvia Farè; Maria Cristina Tanzi
Journal:  J Mater Sci Mater Med       Date:  2011-10-13       Impact factor: 3.896

Review 6.  Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.

Authors:  Donald O Freytes; Laura Santambrogio; Gordana Vunjak-Novakovic
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

7.  Influence of direct or indirect contact for the cytotoxicity and blood compatibility of spider silk.

Authors:  J W Kuhbier; V Coger; J Mueller; C Liebsch; F Schlottmann; V Bucan; P M Vogt; S Strauss
Journal:  J Mater Sci Mater Med       Date:  2017-07-18       Impact factor: 3.896

8.  The effects of storage and sterilization on de-cellularized and re-cellularized whole lung.

Authors:  Nicholas R Bonenfant; Dino Sokocevic; Darcy E Wagner; Zachary D Borg; Melissa J Lathrop; Ying Wai Lam; Bin Deng; Michael J Desarno; Taka Ashikaga; Roberto Loi; Daniel J Weiss
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

Review 9.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

10.  Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Authors:  Mitchell S Weisenberger; Tara L Deans
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-19       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.